Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bertin

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|March 28, 2024
Comparison of the Capacity of Several Machine Learning Tools to Assist Immunofluorescence-Based Detection of Anti-Neutrophil Cytoplasmic AntibodiesDaniel Bertin, Pierre Bongrand, Nathalie Bardin
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2016
ICARE improves antinuclear antibody detection by overcoming the barriers preventing accreditationDaniel Bertin, Yassin Mouhajir, Pierre Bongrand, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 12, 2007
Small size new silastic drains: life-threatening hypovolemic shock after thoracic surgery associated with a non-functioning chest tubeGregory Clark, Marc Licker, Daniel Bertin, et al.
Clinical & Developmental Immunology|January 24, 2014
Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescenceDaniel Bertin, Noémie Jourde-Chiche, Pierre Bongrand, et al.
Frontiers in Immunology|January 11, 2014
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?Daniel Bertin, Delphine Stephan, Michel Khrestchatisky, et al.
European Journal of Internal Medicine|August 8, 2017
Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?Audrey Benyamine, Daniel Bertin, Xavier Heim, et al.
Autoimmunity Reviews|August 2, 2024
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature reviewMathilde Lambert, Alexandre Brodovitch, Jean-Louis Mège, et al.
Immunologic Research|September 10, 2015
Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritisDaniel Bertin, Sylvain Dubucquoi, Daniela Lakomy, et al.
Cytokine|October 21, 2019
Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kitsDaniel Bertin, Mélanie Serrero, Jean Charles Grimaud, et al.
Clinical and Experimental Immunology|December 23, 2024
Detection of antibodies to infliximab in routine care: a 4-year French retrospective studyDaniel Bertin, Jehanne Aghzadi, Nathalie Balandraud, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|March 28, 2024
Comparison of the Capacity of Several Machine Learning Tools to Assist Immunofluorescence-Based Detection of Anti-Neutrophil Cytoplasmic AntibodiesDaniel Bertin, Pierre Bongrand, Nathalie Bardin
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 9, 2016
ICARE improves antinuclear antibody detection by overcoming the barriers preventing accreditationDaniel Bertin, Yassin Mouhajir, Pierre Bongrand, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 12, 2007
Small size new silastic drains: life-threatening hypovolemic shock after thoracic surgery associated with a non-functioning chest tubeGregory Clark, Marc Licker, Daniel Bertin, et al.
Clinical & Developmental Immunology|January 24, 2014
Original approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescenceDaniel Bertin, Noémie Jourde-Chiche, Pierre Bongrand, et al.
Frontiers in Immunology|January 11, 2014
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?Daniel Bertin, Delphine Stephan, Michel Khrestchatisky, et al.
European Journal of Internal Medicine|August 8, 2017
Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?Audrey Benyamine, Daniel Bertin, Xavier Heim, et al.
Autoimmunity Reviews|August 2, 2024
Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: A literature reviewMathilde Lambert, Alexandre Brodovitch, Jean-Louis Mège, et al.
Immunologic Research|September 10, 2015
Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritisDaniel Bertin, Sylvain Dubucquoi, Daniela Lakomy, et al.
Cytokine|October 21, 2019
Monitoring of infliximab trough levels and anti-infliximab antibodies in inflammatory bowel diseases: A comparison of three commercially available ELISA kitsDaniel Bertin, Mélanie Serrero, Jean Charles Grimaud, et al.
Clinical and Experimental Immunology|December 23, 2024
Detection of antibodies to infliximab in routine care: a 4-year French retrospective studyDaniel Bertin, Jehanne Aghzadi, Nathalie Balandraud, et al.
Pageof 4